Table 1 Overview of the MS patient cohort (n = 728).
From: Cost patterns of long-term prescribed medications in patients with multiple sclerosis in Germany
Characteristic | Statistics | Characteristic | Statistics |
|---|---|---|---|
Sociodemographic data | Clinical data | ||
Age (years), mean ± SD | 48.6 ± 13.2 | Medical center, n (%) | |
Sex, n (%) | Rostock | 421 (57.8) | |
Women | 519 (71.3) | Mühlhausen | 206 (28.3) |
Men | 209 (28.7) | Greifswald | 101 (13.9) |
Place of residence, n (%) | Patient care, n (%) | ||
Rural area | 274 (37.6) | Outpatient | 493 (67.7) |
Provincial town | 125 (17.2) | Inpatient | 235 (32.3) |
Medium-sized town | 146 (20.1) | Disease course, n (%) | |
City | 183 (25.1) | CIS/RRMS | 483 (66.3) |
School years, median (range) | 10 (6–18) | SPMS | 176 (24.2) |
Educational level, n (%) | PPMS | 69 (9.5) | |
No training | 27 (3.7) | EDSS score, mean ± SD | 3.6 ± 2.1 |
Skilled worker | 459 (63.0) | Disease duration (years), median (range) | 10 (0–52) |
Technical college | 105 (14.4) | Number of comorbidities, median (range) | 1 (0–9) |
University | 137 (18.8) | ||
Employment status, n (%) | |||
Employed | 299 (41.1) | Medication data | |
Unemployed | 31 (4.3) | Long-term Rx medications, mean ± SD | 3.7 ± 2.7 |
Retired | 364 (50.0) | DMD use, n (%) | |
Other | 34 (4.7) | Yes | 584 (80.2) |
Living in a partnership, n (%) | No | 144 (19.8) | |
Yes | 528 (72.5) | Symptomatic Rx medications, mean ± SD | 1.2 ± 1.5 |
No | 200 (27.5) | Comorbidity Rx medications, mean ± SD | 1.7 ± 2.0 |
